Note: ICD-10-CM was scheduled to go into effect on October 1, 2014. In April 2014, the date was changed to October 1, 2015. Continue to use ICD-9-CM for casefinding for 2014.
These tables are also available in a printable version (PDF, 162 KB).
Please refer to your standard setter(s) for specific reporting requirements before using the Casefinding list
Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors (Effective 10/1/2014-9/30/2015)
ICD-10-CM CODE^ | Explanation OF ICD-10-CM CODE |
---|---|
C00._ - C43._, C45._ - C96._ | Malignant neoplasms (excluding category C44), stated or presumed to be primary (of specified site) and certain specified histologies 1 |
C44.00, C44.09 | Unspecified/other malignant neoplasm of skin of lip |
C44.10_, C44.19_ | Unspecified/other malignant neoplasm of skin of eyelid |
C44.20_, C44.29_ | Unspecified/other malignant neoplasm skin of ear and external auricular canal |
C44.30_, C44.39_ | Unspecified/other malignant neoplasm of skin of other/unspecified parts of face |
C44.40, C44.49 | Unspecified/other malignant neoplasm of skin of scalp & neck |
C44.50_, C44.59_ | Unspecified/other malignant neoplasm of skin of trunk |
C44.60_, C44.69_ | Unspecified/other malignant neoplasm of skin of upper limb, incl. shoulder |
C44.70_, C44.79_ | Unspecified/other malignant neoplasm of skin of lower limb, including hip |
C44.80, C44.89 | Unspecified/other malignant neoplasm of skin of overlapping sites of skin |
C44.90, C44.99 | Unspecified/other malignant neoplasm of skin of unspecified sites of skin |
D00._ - D09._ | In-situ neoplasms (Note: Carcinoma in situ of the cervix (CIN III-8077/2) and Prostatic Intraepithelial Carcinoma (PIN III-8148/2) are not reportable). |
D18.02 | Hemangioma of intracranial structures and any site |
D18.1 | Lymphangioma, any site (Note: Includes Lymphangiomas of Brain, Other parts of nervous system and endocrine glands, which are reportable) |
D32._ | Benign neoplasm of meninges (cerebral, spinal and unspecified) |
D33._ | Benign neoplasm of brain and other parts of central nervous system |
D35.2 - D35.4 | Benign neoplasm of pituitary gland, craniopharyngeal duct and pineal gland |
D42._, D43._ | Neoplasm of uncertain or unknown behavior of meninges, brain, CNS |
D44.3 - D44.5 | Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland |
D45 | Polycythemia vera (9950/3) |
D46._ | Myelodysplastic syndromes (9980, 9982, 9983, 9985, 9986, 9989, 9991, 9992) |
D47.1 | Chronic myeloproliferative disease (9963/3) |
D47.3 | Essential (hemorrhagic) thrombocythemia (9962/3) |
D47.4 | Osteomyelofibrosis (9961/3) |
D47.7 | Other specified neoplasms of uncertain/unknown behavior of lymphoid, hematopoietic (9965/3, 9966/3, 9967/3, 9971/3, 9975/3) |
D47.Z_ | Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified (9960/3, 9970/1, 9931/3) |
D47.9 | Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified (9970/1, 9931/3) |
D49.6, D49.7 | Neoplasm of unspecified behavior of brain, endocrine glands and other CNS |
1Note: Pilocytic/juvenile astrocytoma M-9421 moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. However, SEER registries will CONTINUE to report these cases and code behavior as /3 (malignant).
NOTE: Cases with these codes should be screened as registry time allows. Experience in the SEER registries has shown that using the supplemental list increases casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases
SUPPLEMENTAL LIST ICD-10-CM
(EFFECTIVE DATES: 10/1/2014-9/30/2015)
ICD-10-CM CODE^ | EXPLANATION OF ICD-10-CM CODE |
---|---|
B20 | Human immunodeficiency virus [HIV] disease with other diseases |
B97.33, B97.34, B97.35 |
Human T-cell lymphotrophic virus,( type I [HTLV-1], type II [HTLV-II], type 2 [HIV 2]) as the cause of diseases classified elsewhere |
B97.7 | Papillomarvirus as the cause of diseases classified elsewhere |
C44.01, C44.02 | Basal/squamous cell carcinoma of skin of lip |
C44.11_, C44.12_ | Basal/squamous cell carcinoma of skin of eyelid |
C44.21_, C44.22_ | Basal/squamous cell carcinoma of skin of ear and external auricular canal |
C44.31_, C44.32_ | Basal/squamous cell carcinoma of skin of other and unspecified parts of face |
C44.41, C44.42 | Basal/squamous cell carcinoma of skin of scalp and neck |
C44.51_, C44.52_ | Basal/squamous cell carcinoma of skin of trunk |
C44.61_, C44.62_ | Basal/squamous cell carcinoma of skin of upper limb, including shoulder |
C44.71_, C44.72_ | Basal/squamous cell carcinoma of skin of lower limb, including hip |
C44.81, C44.82 | Basal/squamous cell carcinoma of skin of overlapping sites of skin |
C44.91, C44.92 | Basal/squamous cell carcinoma of skin of unspecified sites of skin |
D10._ - D31._, D34, D35.0, D35.1, D35.5_ D35.9, D36._ |
Benign neoplasms (see "must collect" list for reportable benign neoplasms) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors Note: Borderline cystadenomas M-8442, 8451, 8462, 8472, 8473, of the ovaries moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. SEER registries are not required to collect these cases for diagnoses made 1/1/2001 and after. However, cases diagnosed prior to 1/1/2001 should still be abstracted and reported to SEER. |
D3A._ | Benign carcinoid tumors |
D37._ - D41._ | Neoplasms of uncertain or unknown behavior (see "must collect" list for reportable neoplasms of uncertain or unknown behavior) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors |
D44.0 - D44.2, D44.6-D44.9 |
Neoplasm of uncertain or unknown behavior of other endocrine glands (see "must collect" list for D44.3-D44.5) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors |
D47.0 | Histiocytic and mast cell tumors of uncertain behavior |
D47.2 | Monoclonal gammopathy Note: Screen for incorrectly coded Waldenstrom's macroglobulinemia |
D48._ | Neoplasm of uncertain behavior of other and unspecified sites |
D49.0 - D49.9 | Neoplasm of unspecified behavior (except for D49.6 and D49.7) |
D61.18_ | Pancytopenia |
D63.0 | Anemia in neoplastic disease |
D64.81 | Anemia due to antineoplastic chemotherapy |
D69.49, D69.59, D69.6 |
Other thrombocytopenia Note: Screen for incorrectly coded thrombocythemia |
D70.1 | Agranulocytosis secondary to cancer chemotherapy |
D72.1 | Eosinophilia (Note: Code for eosinophilia (9964/3). Not every case of eosinophilia is a malignancy. Reportable Diagnosis is "Hypereosonophilic syndrome.") |
D76._ | Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue |
D89.0, D89.1 | Other disorders involving the immune mechanism, not elsewhere classified Note: Review for miscodes |
E34.0 | Carcinoid syndrome |
E83.52 | Hypercalcemia |
E88.09 | Other disorders of plasma-protein metabolism, not elsewhere classified |
E88.3 | Tumor lysis syndrome (following antineoplastic chemotherapy) |
G89.3 | Neoplasm related pain (acute)(chronic) |
K22.711 | Barrett's esophagus with high grade dysplasia |
K62.82 | Dysplasia of anus (AIN I and AIN II) |
K92.81 | Gastrointestinal mucositis (ulcerated) (due to antineoplastic therapy) |
N42.3 | Dysplasia of prostate (PIN I and PIN II) |
N87._ | Dysplasia of cervix uteri (CIN I and CIN II) |
N89.0, N89.1, N89.3 |
Vaginal dysplasia (VIN I and VIN II) |
N90.0, N90.1, N90.3 |
Vulvar dysplasia (VAIN I and VAIN II) |
O01._ | Hydatidiform mole Note: Benign tumor that can become malignant. If malignant, report as Choriocarcinoma (9100/3, ) malignancy code in the C00- C97 range |
Q85.0_ | Neurofibromatosis (nonmalignant) (9540/1) Note: Neurofibromatosis is not cancer. These tumors can be precursors to acoustic neuromas, which are reportable |
R18.0 | Malignant ascites |
R53.0 | Neoplastic (malignant) related fatigue |
R59._ | Enlarged lymph nodes |
R85.6 | Abnormal findings on cytological and histological examination of digestive organs |
R87.61_, R87.62_ | Abnormal findings on cytological/histological examination of female genital organs |
R92._ | Abnormal findings on diagnostic imaging of breast |
R97._ | Abnormal tumor markers |
T38.8_, T38.9_ | Poisoning by hormones and their synthetic substitutes |
T45.1_ | Poisoning by, adverse effect of and under dosing of antineoplastic and immunosuppressive drugs |
T45.8_, T45.9_ | Poisoning by primary systemic and hematological agent, unspecified |
T66 | Unspecified effects of radiation |
T80.2_ | Infections following infusion, transfusion and therapeutic injection |
Y63.2 | Overdose of radiation given during therapy |
Y84.2 | Radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure |
Z03.89 | Encounter for observation for other suspected diseases and conditions ruled out |
Z08 | Encounter for follow-up examination after completed treatment for malignant neoplasm |
Z12._ | Encounter for screening for malignant neoplasms |
Z17.0, Z17.1 | Estrogen receptor positive and negative status |
Z40.0_ | Encounter for prophylactic surgery for risk factors related to malignant neoplasms |
Z42.1 | Encounter for breast reconstruction following mastectomy |
Z48.290 | Encounter for aftercare following bone marrow transplant |
Z51.0 | Encounter for antineoplastic radiation therapy |
Z51.1_ | Encounter for antineoplastic chemotherapy and immunotherapy |
Z51.5, Z51.89 | Encounter for palliative care and other specified aftercare |
Z85._ | Personal history of malignant neoplasm |
Z86.0_, Z86.01_, Z86.03 |
Personal history of in situ and benign neoplasms and neoplasms of uncertain behavior |
Z92.21, Z92.23, Z92.25. Z92.3 |
Personal history of antineoplastic chemotherapy, estrogen therapy, immunosuppression therapy or irradiation (radiation) |
Z94.81, Z94.84 | Bone marrow and stem cell transplant status |
^International Classification of Diseases, ICD-10-CM Tabular List of Diseases and Injuries, FY 2014